Home
Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainmadrigalpharma.com

Year Founded2011

Employees501 - 1000

Annual Revenue$500M - $1B

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals (including company regionals)

madrigalpharma.com

See more website traffic and engagement information

Madrigal Pharmaceuticals Revenue up to November 2025 is 500M - 1B

revenue generated by Madrigal Pharmaceuticals top domains

Madrigal Pharmaceuticals top domains revenue over 3 years

Revenue for Madrigal Pharmaceuticals top domains

madrigalpharma.com500M - 1B

See more with Sales Intelligence

Total visits to Madrigal Pharmaceuticals's top domains

Understand Madrigal Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

madrigalpharma.com34.5K

See more with Sales Intelligence

Avg. visit duration in Madrigal Pharmaceuticals's top domains

Analyze Madrigal Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

madrigalpharma.com00:01:07

See more with Sales Intelligence

Avg. pageviews on Madrigal Pharmaceuticals's top domains

See how Madrigal Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

madrigalpharma.com2.12

See more with Sales Intelligence

Madrigal Pharmaceuticals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

portola.comCompany NamePortola Pharmaceuticals IncEmployees201 - 500HQUnited States, California, South San FranciscoAnnual revenue$100M - $200MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Madrigal Pharmaceuticals

These are the website technologies, by industry, used by Madrigal Pharmaceuticals top domains

Widget (6)

Twemoji

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

More Technologies

10

See all

News & Signals from Madrigal Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMadrigalpharma hired Soergel as Executive Vice President and Global Head of Cardiovascular, Renal, and Metabolism Development on Jan 1st '24.Dr. Soergel joins Madrigal from Novartis, where he served as the Executive Vice President and Global Head of Cardiovascular, Renal, and Metabolism Development, overseeing 10 late-stage development programs in 2024.

NewsMadrigalpharma attends event 45th Annual TD Cowen Health Care Conference.Madrigal Pharmaceuticals to participate in the 45th Annual TD Cowen Health Care Conference.

NewsMadrigalpharma hired Michael R. Charlton as Senior Vice President, Clinical Development on Oct 1st '24.CONSHOHOCKEN, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) - Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH)/metabolic dysfunction-associated steatohepatitis (MASH), today announced the appointment of Michael R. Charlton, M.B.B.S., F.R.C.P., as Senior Vice President, Clinical Development, effective October 1, 2024.